From tomorrow, the company will be part of the diagnostics division of Abbott Laboratories.
Today was the last day of trading on the Tel Aviv Stock Exchange (TASE) for StarLIMS Technologies Ltd. (Nasdaq:LIMS); TASE: LIMS). From tomorrow, the company will be part of the diagnostics division of Abbott Laboratories Inc. (NYSE: ABT).
StarLIMS was founded by CEO Itschak Friedman and his brother, CFO Chaim Friedman. The company develops laboratory information management systems (LIMS). Itschak Friedman will get $21.6 million for his shares in the company, and Chaim will get $8.1 million. Abbott paid $123 million altogether for the company.
Published by Globes [online], Israel business news - www.globes-online.com - on March 21, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010
Shiri Habib-Valdhorn and Gali Weinreb